BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24886967)

  • 21. Synaptic proteins in the hippocampus indicative of increased neuronal activity in CA3 in schizophrenia.
    Li W; Ghose S; Gleason K; Begovic A; Perez J; Bartko J; Russo S; Wagner AD; Selemon L; Tamminga CA
    Am J Psychiatry; 2015 Apr; 172(4):373-82. PubMed ID: 25585032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinolinic acid enhances permeability of rat brain microvessels to plasma albumin.
    St'astný F; Skultétyová I; Pliss L; Jezová D
    Brain Res Bull; 2000 Nov; 53(4):415-20. PubMed ID: 11136997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
    Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
    Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implication of neuronal Ca2+ -sensor protein VILIP-1 in the glutamate hypothesis of schizophrenia.
    Gierke P; Zhao C; Bernstein HG; Noack C; Anand R; Heinemann U; Braunewell KH
    Neurobiol Dis; 2008 Oct; 32(1):162-75. PubMed ID: 18691652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
    Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
    J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gestational and postnatal malnutrition affects sensitivity of young rats to picrotoxin and quinolinic acid and uptake of GABA by cortical and hippocampal slices.
    Schweigert ID; de Oliveira DL; Scheibel F; da Costa F; Wofchuk ST; Souza DO; Perry ML
    Brain Res Dev Brain Res; 2005 Feb; 154(2):177-85. PubMed ID: 15707671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potentiation of the NMDA receptor-mediated responses through the activation of the glycine site by microglia secreting soluble factors.
    Hayashi Y; Ishibashi H; Hashimoto K; Nakanishi H
    Glia; 2006 Apr; 53(6):660-8. PubMed ID: 16498631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kainic acid-activated microglia mediate increased excitability of rat hippocampal neurons in vitro and in vivo: crucial role of interleukin-1beta.
    Zheng H; Zhu W; Zhao H; Wang X; Wang W; Li Z
    Neuroimmunomodulation; 2010; 17(1):31-8. PubMed ID: 19816055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring.
    Oh-Nishi A; Obayashi S; Sugihara I; Minamimoto T; Suhara T
    Brain Res; 2010 Dec; 1363():170-9. PubMed ID: 20863817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective alterations in ionotropic glutamate receptors in the anterior cingulate cortex in schizophrenia.
    Zavitsanou K; Ward PB; Huang XF
    Neuropsychopharmacology; 2002 Nov; 27(5):826-33. PubMed ID: 12431856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.
    Errico F; Napolitano F; Squillace M; Vitucci D; Blasi G; de Bartolomeis A; Bertolino A; D'Aniello A; Usiello A
    J Psychiatr Res; 2013 Oct; 47(10):1432-7. PubMed ID: 23835041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of dopaminergic neurotransmission in the medial prefrontal cortex by N-methyl-d-aspartate stimulation of the ventral hippocampus in rats.
    Peleg-Raibstein D; Pezze MA; Ferger B; Zhang WN; Murphy CA; Feldon J; Bast T
    Neuroscience; 2005; 132(1):219-32. PubMed ID: 15780480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2-Iminothiazolidine-4-carboxylic acid produces hippocampal CA1 lesions independent of seizure excitation and glutamate receptor activation.
    Bitner RS; Yim GK; Isom GE
    Neurotoxicology; 1997; 18(1):191-200. PubMed ID: 9216001
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo modulation of nitric oxide concentration dynamics upon glutamatergic neuronal activation in the hippocampus.
    Lourenço CF; Santos R; Barbosa RM; Gerhardt G; Cadenas E; Laranjinha J
    Hippocampus; 2011 Jun; 21(6):622-30. PubMed ID: 20169537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic intermittent ethanol exposure enhances NMDA-receptor-mediated synaptic responses and NMDA receptor expression in hippocampal CA1 region.
    Nelson TE; Ur CL; Gruol DL
    Brain Res; 2005 Jun; 1048(1-2):69-79. PubMed ID: 15919065
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SNAP-25 reduction in the hippocampus of patients with schizophrenia.
    Thompson PM; Egbufoama S; Vawter MP
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):411-7. PubMed ID: 12691775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of ionotropic glutamate receptor-mediated processes in the rat hippocampus following repeated, brief seizures.
    Borbély S; Dobó E; Czégé D; Molnár E; Bakos M; Szucs B; Vincze A; Világi I; Mihály A
    Neuroscience; 2009 Mar; 159(1):358-68. PubMed ID: 19154779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastriatal administration.
    Pérez P; Flores A; Santamaría A; Ríos C; Galván-Arzate S
    Arch Med Res; 1996; 27(4):449-52. PubMed ID: 8987176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kynurenic acid and quinolinic acid act at N-methyl-D-aspartate receptors in the rat hippocampus.
    Ganong AH; Cotman CW
    J Pharmacol Exp Ther; 1986 Jan; 236(1):293-9. PubMed ID: 2867215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study.
    Steiner J; Brisch R; Schiltz K; Dobrowolny H; Mawrin C; Krzyżanowska M; Bernstein HG; Jankowski Z; Braun K; Schmitt A; Bogerts B; Gos T
    Schizophr Res; 2016 Nov; 177(1-3):10-17. PubMed ID: 26922657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.